SpaceX Shorts Keep Covering, But the Target Gap Stays Wide

SPCX has stabilised around $148 this week, a narrow one-month trading range that sits more than 70% below where most analysts think the stock belongs, and short sellers have been quietly reducing exposure for the past month.

Bears have been in retreat across October. Short interest has fallen 12% over the past month and nearly 6% over the past week alone, reaching roughly 164.8 million shares. That is a consistent, steady unwind rather than a panic cover. The ORTEX short score, which had been running above 50 for most of the month, dropped to 44.4 by October 27, its lowest reading in the visible history for this period. Borrow costs have followed the same direction, easing to 0.42% from around 0.57% a month ago, a level that classifies as low. Availability has loosened materially, with 256% of short interest now sitting available to borrow, up from roughly 148% in late September, meaning the lending pool is well-supplied relative to what is actually borrowed. The options market is not amplifying bearish pressure either. The put/call ratio has eased to 0.95, now about 1.5 standard deviations below its 20-day average of 1.00. Across short interest, borrow, availability and options, the positioning tells one consistent story: residual bears are stepping back.

The Street is uniformly bullish, and that has been the case for weeks. After the Q3 print on October 20, a wave of analysts raised targets on the same day, and BofA's Ronald Epstein followed with a further lift on October 22, taking his target to $275. The consensus mean now sits at $256.59 against a price of $148.58, a return potential of around 73%, which remains one of the widest gaps in US large-cap coverage. The JP Morgan target of $500, lifted from $240 in a single move, is an outlier that pulls the mean higher, but even the more measured targets from UBS ($230), Citigroup ($240) and Macquarie ($250) imply 55% to 68% upside. The bear case, as framed by Benzinga, rests on execution risk around the company's $40 billion GPU debt financing, potential semiconductor supply constraints, and the assumption that AI data center leasing demand holds at the pace management is projecting. Bulls point to Q3 Super Intelligence segment revenue of $7.6 billion with $5 billion EBITDA, total company revenue of $14.6 billion, and management guidance for $100 billion ARR by year-end.

The ownership register underscores why the stock moves slowly relative to analyst noise. Elon Musk holds 44.7% of shares as of the most recent disclosure. Alphabet holds a further 4.1%, Peter Thiel's Founders Fund 3.1%, and Valor Management added 88.2 million shares as of September 11, bringing its stake to 3.4%. The float available to trade is structurally narrow, given the concentration among strategic and early-stage holders, which caps the stock's price velocity in either direction regardless of what short sellers do. All four large shareholders filed Schedule 13G (passive), and ORTEX carries no 13D activist on the register. The insider activity from September was driven by COO Gwynne Shotwell, who exercised and sold roughly $52.5 million of stock through pre-arranged 10b5-1 plans, not a discretionary signal.

The next earnings event is scheduled for November 5. Two previous prints produced sharply opposite one-day reactions: a gain of 7.7% after the October 20 Q3 release, and a fall of 8.3% after the August 5 print. With the short score now at its lowest recent level and borrow availability comfortable, the lending market is not pricing in stress ahead of that date. The November print will be watched for early evidence on whether the $40 billion GPU financing is generating the AI infrastructure revenue run rate management projected.